A.P. Moller – Maersk has announced the signing of a logistics agreement with Novo Nordisk effective from 2021.
The three-year agreement on cold chain logistics covers transportation including ocean services and inland logistics.
Vincent Clerc, Executive Vice President and CEO Ocean and Logistics. A.P. Moller – Maersk said: “We are proud to be chosen as one of Novo Nordisk’s main logistic companies.
“Transporting pharmaceuticals on a global level is a demanding task with various complexities that require flexible and resilient supply chains as well as digital and eco-friendly solutions.
“This achievement showcases the rapid transformation of A.P. Moller – Maersk as a modern end-to-end logistics company with fully controlled assets.”
Maersk and COVAXX Partner to Supply COVID-19 Vaccines Globally
One of the largest pharmaceutical companies in the world, Novo Nordisk has chosen Maersk´s ECO Delivery to reduce the carbon footprint in transportation.
The initiative uses sustainable biofuel to power selected Maersk-vessels and helps Novo Nordisk to make progress towards its ambitious sustainability goals.
Rune Sylow, Corporate Vice President, Strategic Sourcing Novo Nordisk said: “Our ambition of achieving zero environmental impact is a cornerstone of our aspiration to be a truly sustainable business.
“We consider A.P. Moller – Maersk to be the right global distribution partner to secure the steady, environmentally friendly delivery of our high-value shipments and we look forward to the collaboration.”
Watch: Maersk Meets COVID-19 Challenge with Dedication and Innovation
